J. Wu

248 High incidence of isolated brain metastases (CNSMets) following complete response (CR) in advanced non-small cell lung cancer (NSCLC): A new challenge

T. Dipetrillo, M. Garcia-Moliner, D. Karp, 1997 .

The influence of therapeutic vaccine candidate against HBeAg pEGFP-N1-C (472-507)-ecdCD40L on dendritic cells.

L. Zheng, H. Zhang, X. Lin, 2018, Acta virologica.

25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province.

Jonn Wu, W. Cheung, R. Olson, 2014, Oral oncology.

Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study

Z. Cai, L. Zhang, L. Zhao, 2016, Blood Cancer Journal.

MA15.11 Real World Biomarker Testing and Treatment Patterns in Patients with Advanced NSCLC Receiving EGFR-TKIs

J. Subramanian, A. Chiang, N. Chehab, 2018, Journal of Thoracic Oncology.

O-1 Results from a global phase 2 study of tislelizumab, an investigational PD-1 antibody, in patients with unresectable hepatocellular carcinoma

M. Ducreux, G. Abou-Alfa, L. Rimassa, 2021, Annals of Oncology.

OC-0557 AI-based NSCLC detection and segmentation: faster and more prognostic than manual segmentation

Olivier Morin, Philippe Lambin, Henry C. Woodruff, 2021, Radiotherapy and Oncology.

17. Phase II study of oxaliplatin plus S-1 as neoadjuvant chemotherapy for advanced gastric cancer: Response and safety results

J. Ji, Ziyu Li, Xiaojiang Wu, 2012 .